Cordyceps Sunshine Biotech Holdings (RAJAF) Current Leases (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Current Leases history runs 6 years deep, the most recent figure standing at $13173.0 for Q4 2025.

• In Q4 2025, Current Leases fell 84.86% year-over-year to $13173.0; the TTM figure through Dec 2025 stood at $13173.0 (down 84.86% YoY), while the FY2025 annual figure was $13173.0, down 84.86% from the prior year.
• Current Leases was $13173.0 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, down from $87016.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $99055.0 in Q3 2023 to a low of $13173.0 in Q4 2025.
• Historically, Current Leases has averaged $68780.2 across 5 years, with a median of $76626.5 in 2021.
• The sharpest annual moves came in 2021 and 2025: Current Leases jumped 1309.6% in 2021, then plunged 84.86% in 2025.
• A 5-year view of Current Leases shows it stood at $66237.0 in 2021, then slipped by 13.78% to $57109.0 in 2022, then surged by 57.75% to $90091.0 in 2023, then dropped by 3.41% to $87016.0 in 2024, then slumped by 84.86% to $13173.0 in 2025.
• The last three Current Leases figures came in at $13173.0 (Q4 2025), $87016.0 (Q4 2024), and $90091.0 (Q4 2023), per Business Quant data.